7.3 Gastro-oesophageal reflux
Pathophysiology
In infants the LES is located above the diaphragm, rendering the above protective mechanisms ineffective. Therefore, infants are especially prone to GOR, particularly in the early months of life. However, with anatomical and physiological maturation, the natural history is of symptom resolution by late infancy in the vast majority. GOR is unusual in children older than 18 months.1
Differential diagnosis
There are many causes of vomiting in children, and it is important to consider a number of alternative causes that may mimic GOR (see Chapter 7.8 on Diarrhoea and vomiting). These include: infection, e.g. urinary tract infection, gastroenteritis; surgical conditions, e.g. malrotation and volvulus, pyloric stenosis, intussusception; metabolic disorders, e.g. inborn errors, diabetes; food allergy and raised intracranial pressure, e.g. hydrocephalus, posterior fossa tumour, subdural haematoma (Table 7.3.1).
Complications
GOR may result in serious complications and is then referred to as GORD.
Respiratory
A number of respiratory complications may occur with GOR. Recurrent aspiration (often silent) results in chronic wheeze or cough, and alveolar disease may develop, with signs of tachypnoea and increased work of breathing. Exposure of the oesophageal mucosa to acid can trigger reflex bronchospasm, and persistent asthma symptoms may occasionally be related to GOR.2 Intermittent (or even isolated) episodes of aspiration can cause pneumonia. Reflux of gastric contents into the upper airway can result in laryngospasm, presenting as an obstructive apnoea or apparent life-threatening event (ALTE).3 However, it is unusual to be able to demonstrate an association between GOR and ALTE.
Oesophagitis
Reflux oesophagitis has become a popular clinical diagnosis given to infants presenting with excessive crying behaviour (so-called ‘silent reflux’). There are many causes for infant distress, (including temperamental factors, food allergy) and peptic oesophagitis is only responsible for a minority of cases of infant distress.4 These infants may have episodes of blood in the vomitus or develop iron deficiency anaemia due to the red cell loss. Rarely, an infant may develop feed aversion due to the distress of GOR.
Investigations
Oesophageal pH monitoring over 24 hours provides representative data about the pH at the lower oesophageal mucosa. A number of indices can be calculated from the monitoring: the frequency of GOR episodes; the length of episodes; and the reflux index – the proportion of time sampled that the oesophageal pH was less than 4 (exposure to gastric acid greater than 10% is usually considered abnormal). However, the association of GOR with oesophagitis is not strong. Infants often have abnormal oesophageal pH findings in the absence of histological features of oesophagitis and, conversely, infants with oesophagitis may have no evidence of significant GOR on pH study.4 These infants presumably have an alternative cause for their oesophagitis, such as allergy. The precise role of oesophageal pH studies is contentious. It is a good test to confirm severe GOR prior to embarking on antireflux surgery, and there may be other clinical scenarios where it provides useful information, e.g. in conjunction with monitoring of respiratory rate, heart rate and oxygen saturations in investigation of apnoea or episodic hypoxaemia/bradycardia.
Treatment
Simple measures
A number of conservative measures are commonly used to reduce the symptoms of GOR. These include posturing (elevation of cot ~30 degrees head up), thickening of feeds,5 and changes to infant formulas. None of these have been demonstrated to modify clinical outcomes.6 A trial of a partially hydrolysed formula may be indicated in GORD, e.g. GOR with failure to thrive. Prone sleeping position is best for reducing GOR7 but is not generally recommended as it as associated with sudden infant death syndrome. Suggesting positioning a towel on the carer’s shoulder may decrease the inconvenience of refluxed milk onto the parent during feeding.
Pharmacological
Pharmacological treatment of otherwise well, thriving infants with uncomplicated benign GOR is not indicated.8
In more severe cases, the pharmacological options include antacids, antisecretory therapies, and prokinetic agents. High-dose antacids can be effective in treating oesophagitis.9 However, prolonged use can be associated with aluminium toxicity and is not recommended. H2-receptor antagonists such as ranitidine have been shown to improve both histological changes and symptoms.10 Proton pump inhibitors have well-demonstrated clinical efficacy in children with reflux oesophagitis11,12 and appear to be safe. Prokinetic agents do not have clear evidence for symptom reduction;13 however, a trial of domperidone or erythromycin may be worthwhile in GORD.
1 Campanozzi A., Boccia G., Pensabene L., et al. Prevalence and natural history of gastroesophageal reflux: pediatric prospective survey. Pediatrics. 2009;123:779.
2 Balson B.M., Kravitz E.K., McGeady S.J. Diagnosis and treatment of gastroesophageal reflux in children and adolescents with severe asthma. Ann Allergy Asthma Immunol. 1998;81:159-164.
3 Menon A.P., Schefft G.L., Thach B.T. Apnea associated with regurgitation in infants. J Pediatr. 1985;106:625-629.
4 Heine R.G., Cameron D.J.S., Chow C.W., et al. Esophagitis in distressed infants: Poor diagnostic agreement between esophageal pH monitoring and histopathologic findings. J Pediatr. 2002;140:14-19.
5 Horvath A., Dziechciarz P., Szajewska H. The effect of thickened-feed interventions on gastroesophageal reflux in infants: systematic review and meta-analysis of randomized controlled trials. Pediatrics. 2008;122:e1268.
6 Carroll A.E., Garrison M.M., Christakis D.A. A systematic review of nonpharmacological and nonsurgical therapies for gastroesophageal reflux in infants. Arch Pediatr Adolesc Med. 2002;156:109-113.
7 Meyers W.F., Herbst J.J. Effectiveness of positioning therapy for gastroesophageal reflux. Paediatrics. 1982;69:768-782.
8 Khoshoo V., Edell D., Thompson A., Rubin M. Are we overprescribing antireflux medications for infants with regurgitation? Pediatrics. 2007;120:946.
9 Cucchiara S., Staniano A., Romaniello G., et al. Antacids and cimetidine treatment for gastroesophageal reflux and peptic oesophagitis. Arch Dis Child. 1984;59:842-847.
10 Simeone D., Caria M.C., Miele E., et al. Treatment of childhood peptic oesophagitis: A double-blind placebo-controlled trial of nizatidine. J Pediatr Gastroenterol Nutr. 1997;25:51-55.
11 Kato S., Ebina K., Fujii K., et al. Effect of omeprazole in the treatment of refactory acid-related diseases in childhood: Endoscopic healing and twenty-four hour intragastric acidity. J Pediatr. 1996;128:415-421.
12 DeGiacomo C., Bawa P., Franceschi M., et al. Omeprazole for severe gastroesophageal reflux in children. J Pediatr Gastroenterol Nutr. 1997;24:528-532.
13 Augood C., MacLennan S., Gilbert R., Logan S. Cisapride treatment for gastro-oesophageal reflux in children (Cochrane Review). In: The Cochrane Library. Chichester: John Wiley & Sons; 2002. Issue 4